{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:59:12Z","timestamp":1782219552288,"version":"3.54.5"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"MEXT\/JSPS KAKENHI","award":["18KK0228 19H03620"],"award-info":[{"award-number":["18KK0228 19H03620"]}]},{"name":"MEXT\/JSPS KAKENHI","award":["22H03041"],"award-info":[{"award-number":["22H03041"]}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP20ek0109480"],"award-info":[{"award-number":["JP20ek0109480"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,25]]},"abstract":"<jats:p>STAT1 dysfunction causes a wide range of immune dysregulation phenotypes, which have been classified into four disease types, namely, (i) autosomal recessive (AR) complete STAT1 deficiency, (ii) AR partial STAT1 deficiency, (iii) autosomal dominant (AD) STAT1 deficiency, and (iv) AD STAT1 gain of function (GOF), based on their mode of inheritance and function. Disease types (i, ii, and iii) are caused by STAT1 loss-of-function (LOF) mutations, whereas disease type (iv) is caused by STAT1 GOF mutations. Therefore, the functional analysis of mutations is necessary for the precise diagnosis.<\/jats:p>","DOI":"10.1093\/cei\/uxac106","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T08:02:47Z","timestamp":1669276967000},"page":"96-106","source":"Crossref","is-referenced-by-count":31,"title":["Inborn errors of immunity with loss- and gain-of-function germline mutations in <i>STAT1<\/i>"],"prefix":"10.1093","volume":"212","author":[{"given":"Takaki","family":"Asano","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hiroshima University, Graduate School of Biomedical and Health Sciences , Hiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Utsumi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University, Graduate School of Biomedical and Health Sciences , Hiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University, Graduate School of Biomedical and Health Sciences , Hiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Karakawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University, Graduate School of Biomedical and Health Sciences , Hiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-5657","authenticated-orcid":false,"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University, Graduate School of Biomedical and Health Sciences , Hiroshima , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"2023042515461602400_CIT0001","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1073\/pnas.86.4.1203","article-title":"Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells","volume":"86","author":"Dale","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023042515461602400_CIT0002","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1101\/gad.3.9.1362","article-title":"Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro","volume":"3","author":"Levy","year":"1989","journal-title":"Genes Dev"},{"key":"2023042515461602400_CIT0003","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1073\/pnas.89.16.7836","article-title":"Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha","volume":"89","author":"Schindler","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023042515461602400_CIT0004","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"2023042515461602400_CIT0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn errors of human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"key":"2023042515461602400_CIT0006","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0092-8674(00)81443-9","article-title":"Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA","volume":"93","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"2023042515461602400_CIT0007","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"2023042515461602400_CIT0008","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coi.2021.02.009","article-title":"Inborn errors of STAT1 immunity","volume":"72","author":"Mizoguchi","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"2023042515461602400_CIT0009","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023042515461602400_CIT0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biochi.2010.02.009","article-title":"STAT1 and pathogens, not a friendly relationship","volume":"92","author":"Najjar","year":"2010","journal-title":"Biochimie"},{"key":"2023042515461602400_CIT0011","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1128\/MCB.22.16.5662-5668.2002","article-title":"Identification of a nuclear Stat1 protein tyrosine phosphatase","volume":"22","author":"ten Hoeve","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2023042515461602400_CIT0012","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1101\/gad.268003","article-title":"DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1","volume":"17","author":"Meyer","year":"2003","journal-title":"Genes Dev"},{"key":"2023042515461602400_CIT0013","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1101\/gad.1485406","article-title":"Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain","volume":"20","author":"Mertens","year":"2006","journal-title":"Genes Dev"},{"key":"2023042515461602400_CIT0014","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.1142963","article-title":"Primary immunodeficiencies: a field in its infancy","volume":"317","author":"Casanova","year":"2007","journal-title":"Science"},{"key":"2023042515461602400_CIT0015","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022,","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41232-021-00159-6","article-title":"Inborn errors of immunity-recent advances in research on the pathogenesis","volume":"41","author":"Yamashita","year":"2021","journal-title":"Inflamm Regen"},{"key":"2023042515461602400_CIT0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12272","article-title":"Inherited and acquired immunodeficiencies underlying tuberculosis in childhood","volume":"264","author":"Boisson-Dupuis","year":"2015","journal-title":"Immunol Rev"},{"key":"2023042515461602400_CIT0018","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"2023042515461602400_CIT0019","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"2023042515461602400_CIT0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy","volume":"40","author":"Okada","year":"2020","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0021","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00439-020-02141-7","article-title":"Human inborn errors of immunity underlying superficial or invasive candidiasis","volume":"139","author":"Puel","year":"2020","journal-title":"Hum Genet"},{"key":"2023042515461602400_CIT0022","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MD.0b013e3181fdd832","article-title":"Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries","volume":"89","author":"de Beaucoudrey","year":"2010","journal-title":"Medicine (Baltim)"},{"key":"2023042515461602400_CIT0023","doi-asserted-by":"crossref","first-page":"e18524","DOI":"10.1371\/journal.pone.0018524","article-title":"IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey","volume":"6","author":"Boisson-Dupuis","year":"2011","journal-title":"PLoS One"},{"key":"2023042515461602400_CIT0024","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"2023042515461602400_CIT0025","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-gamma immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"2023042515461602400_CIT0026","doi-asserted-by":"crossref","first-page":"e2102804118","DOI":"10.1073\/pnas.2102804118","article-title":"Inherited deficiency of stress granule ZNFX1 in patients with monocytosis and mycobacterial disease","volume":"118,","author":"Le Voyer","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023042515461602400_CIT0027","doi-asserted-by":"crossref","first-page":"eaax7965","DOI":"10.1126\/sciimmunol.aax7965","article-title":"Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-beta","volume":"4","author":"Li","year":"2019","journal-title":"Sci Immunol"},{"key":"2023042515461602400_CIT0028","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"2023042515461602400_CIT0029","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"2023042515461602400_CIT0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0031","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"2023042515461602400_CIT0032","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"2023042515461602400_CIT0033","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.4049\/jimmunol.176.8.5078","article-title":"Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo","volume":"176","author":"Chapgier","year":"2006","journal-title":"J Immunol"},{"key":"2023042515461602400_CIT0034","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1172\/JCI37083","article-title":"A partial form of recessive STAT1 deficiency in humans","volume":"119","author":"Chapgier","year":"2009","journal-title":"J Clin Invest"},{"key":"2023042515461602400_CIT0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.coviro.2011.10.016","article-title":"Inborn errors of anti-viral interferon immunity in humans","volume":"1","author":"Sancho-Shimizu","year":"2011","journal-title":"Curr Opin Virol"},{"key":"2023042515461602400_CIT0036","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2011-01-330571","article-title":"Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation","volume":"118","author":"Vairo","year":"2011","journal-title":"Blood"},{"key":"2023042515461602400_CIT0037","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/intimm\/dxaa043","article-title":"Autosomal recessive complete STAT1 deficiency caused by compound heterozygous intronic mutations","volume":"32","author":"Sakata","year":"2020","journal-title":"Int Immunol"},{"key":"2023042515461602400_CIT0038","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1182\/blood-2010-04-280586","article-title":"A novel form of human STAT1 deficiency impairing early but not late responses to interferons","volume":"116","author":"Kong","year":"2010","journal-title":"Blood"},{"key":"2023042515461602400_CIT0039","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10875-010-9480-8","article-title":"Novel STAT1 alleles in a patient with impaired resistance to mycobacteria","volume":"31","author":"Kristensen","year":"2011","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0040","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jaip.2020.06.034","article-title":"A novel complete autosomal-recessive STAT1 LOF variant causes immunodeficiency with hemophagocytic lymphohistiocytosis-like hyperinflammation","volume":"8","author":"Boehmer","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2023042515461602400_CIT0041","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/jimmunol.2001451","article-title":"Genetic, immunological, and clinical features of 32 patients with autosomal recessive STAT1 deficiency","volume":"207","author":"Le Voyer","year":"2021","journal-title":"J Immunol"},{"key":"2023042515461602400_CIT0042","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10875-020-00948-7","article-title":"Successful hematopoietic stem cell transplantation for autosomal recessive STAT1 complete deficiency","volume":"41","author":"Karakawa","year":"2021","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0043","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.1061154","article-title":"Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation","volume":"293","author":"Dupuis","year":"2001","journal-title":"Science"},{"key":"2023042515461602400_CIT0044","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.immunol.20.081501.125851","article-title":"Genetic dissection of immunity to mycobacteria: the human model","volume":"20","author":"Casanova","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"2023042515461602400_CIT0045","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1371\/journal.pgen.0020131","article-title":"Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease","volume":"2","author":"Chapgier","year":"2006","journal-title":"PLoS Genet"},{"key":"2023042515461602400_CIT0046","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10875-012-9659-2","article-title":"A novel STAT1 mutation associated with disseminated mycobacterial disease","volume":"32","author":"Sampaio","year":"2012","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0047","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/humu.22113","article-title":"Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease","volume":"33","author":"Tsumura","year":"2012","journal-title":"Hum Mutat"},{"key":"2023042515461602400_CIT0048","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3324\/haematol.2013.083741","article-title":"Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis","volume":"98","author":"Hirata","year":"2013","journal-title":"Haematologica"},{"key":"2023042515461602400_CIT0049","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaci.2016.09.035","article-title":"Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants","volume":"140","author":"Kagawa","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2016.11.004","article-title":"A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases","volume":"174","author":"Ueki","year":"2017","journal-title":"Clin Immunol"},{"key":"2023042515461602400_CIT0051","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10875-019-00672-x","article-title":"Current status of the management of mendelian susceptibility to mycobacterial disease in mainland China","volume":"39","author":"Ying","year":"2019","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0052","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbrc.2021.11.036","article-title":"Two novel STAT1 mutations cause Mendelian susceptibility to mycobacterial disease","volume":"591","author":"Liu","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2023042515461602400_CIT0053","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaci.2021.05.018","article-title":"Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-gamma","volume":"149","author":"Tsumura","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0054","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","article-title":"Mendelian susceptibility to mycobacterial diseases: state of the art","volume":"28","author":"Noma","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"2023042515461602400_CIT0055","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(04)17552-1","article-title":"Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies","volume":"364","author":"Dorman","year":"2004","journal-title":"Lancet"},{"key":"2023042515461602400_CIT0056","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1189\/jlb.0513250","article-title":"Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis","volume":"95","author":"Mizoguchi","year":"2014","journal-title":"J Leukoc Biol"},{"key":"2023042515461602400_CIT0057","doi-asserted-by":"crossref","first-page":"654406","DOI":"10.3389\/fimmu.2021.654406","article-title":"Clinical relevance of gain- and loss-of-function germline mutations in STAT1: a systematic review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"2023042515461602400_CIT0058","doi-asserted-by":"crossref","first-page":"682350","DOI":"10.3389\/fimmu.2021.682350","article-title":"Case report: disseminated talaromyces marneffei infection in a patient with chronic mucocutaneous Candidiasis and a novel STAT1 gain-of-function mutation","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"2023042515461602400_CIT0059","doi-asserted-by":"crossref","first-page":"760019","DOI":"10.3389\/fimmu.2021.760019","article-title":"Case report: a new gain-of-function mutation of STAT1 identified in a patient with chronic mucocutaneous candidiasis and rosacea-like demodicosis: an emerging association","volume":"12","author":"Martinot","year":"2021","journal-title":"Front Immunol"},{"key":"2023042515461602400_CIT0060","doi-asserted-by":"crossref","first-page":"e13694","DOI":"10.1111\/pai.13694","article-title":"DNA-Binding domain mutations confer severe outcome at an early age among STAT1 gain-of-function patients","volume":"33","author":"Scott","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"2023042515461602400_CIT0061","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0062","doi-asserted-by":"crossref","first-page":"ofx202","DOI":"10.1093\/ofid\/ofx202","article-title":"Risks of Ruxolitinib in STAT1 gain-of-function-associated severe fungal disease","volume":"4","author":"Zimmerman","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2023042515461602400_CIT0063","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","article-title":"Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a Novel STAT1 gain-of-function mutation","volume":"38","author":"Bloomfield","year":"2018","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0064","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jaci.2017.08.040","article-title":"Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations","volume":"141","author":"Vargas-Hernandez","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0065","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12185-020-02860-7","article-title":"Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation","volume":"112","author":"Moriya","year":"2020","journal-title":"Int J Hematol"},{"key":"2023042515461602400_CIT0066","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","article-title":"Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis","volume":"131","author":"Sampaio","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0067","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1074\/jbc.M116.753848","article-title":"Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation","volume":"292","author":"Fujiki","year":"2017","journal-title":"J Biol Chem"},{"key":"2023042515461602400_CIT0068","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jaci.2017.07.027","article-title":"Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation causing gain of function","volume":"141","author":"Sampaio","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2023042515461602400_CIT0069","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10875-018-0557-0","article-title":"Increased STAT1 amounts correlate with the phospho-STAT1 Level in STAT1 gain-of-function defects","volume":"38","author":"Bernasconi","year":"2018","journal-title":"J Clin Immunol"},{"key":"2023042515461602400_CIT0070","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3389\/fimmu.2019.01433","article-title":"STAT1 gain-of-function mutations cause high total STAT1 levels with normal dephosphorylation","volume":"10","author":"Zimmerman","year":"2019","journal-title":"Front Immunol"},{"key":"2023042515461602400_CIT0071","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxac106\/48947382\/uxac106.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/212\/2\/96\/50094183\/uxac106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/212\/2\/96\/50094183\/uxac106.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T16:04:42Z","timestamp":1682438682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/212\/2\/96\/6844014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":71,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,11,24]]},"published-print":{"date-parts":[[2023,4,25]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxac106","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,11,24]]}}}